A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

Condition:   Angioplasty, Transluminal, Percutaneous CoronaryInterventions:   Other: Angioplasty;   Other: Intracoronary Stent;   Drug: Abxicimab;   Drug: Heparin;   Drug: PlaceboSponsor:   Centocor, Inc.Completed - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials